Down syndrome with Alzheimer's disease brains have increased iron and associated lipid peroxidation consistent with

Max A Thorwald1, Jose A Godoy-Lugo1, Elizabeth Kerstiens1

  • 1Leonard Davis School of Gerontology, University of Southern California, Los Angeles, California, USA.

Abstract

Insights

Down syndrome with Alzheimer's disease (DSAD) shows increased iron and lipid peroxidation compared to sporadic Alzheimer's disease (AD). This suggests greater ferroptotic changes in DSAD due to impaired antioxidant defenses in lipid rafts.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Genetics

Background:

  • Cerebral microbleeds (MBs) are linked to Alzheimer's disease (AD) and Down syndrome with AD (DSAD).
  • Elevated iron in MBs can trigger iron-mediated lipid peroxidation.
  • Amyloid precursor protein (APP) triplication may exacerbate iron accumulation and lipid peroxidation.

Purpose of the Study:

  • To investigate the relationship between amyloid deposition, iron load, and lipid peroxidation in AD and DSAD.
  • To examine proteins involved in iron metabolism, antioxidant response, and amyloid processing within lipid rafts.
  • To compare ferroptotic changes in DSAD versus sporadic AD.

Main Methods:

  • Analysis of prefrontal cortex and cerebellum from control, AD, and DSAD individuals (ApoE3,3 carriers).
  • Assessed proteins mediating iron metabolism, antioxidant response, and amyloid processing in lipid rafts.
  • Measured iron levels, iron storage proteins, lipid peroxidation markers, and antioxidant enzyme activity (GCLM, GPx4).

Main Results:

  • Iron levels were twofold higher in DSAD compared to controls and AD.
  • Increased iron storage proteins and lipid peroxidation were observed in the prefrontal cortex of DSAD and AD.
  • Glutathione synthesis protein GCLM decreased by 50% in both AD and DSAD, while lipid raft-associated GPx4 activity decreased by at least 30% in AD and DSAD.

Conclusions:

  • DSAD exhibits greater lipid peroxidation and iron load than sporadic AD, correlating with increased microbleeds.
  • DSAD shows more significant ferroptotic changes than sporadic AD.
  • Impaired antioxidant enzyme activity in lipid rafts involved in APP processing contributes to these findings.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
684
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.9K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
182
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.4K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.9K